No Data
No Data
Evercore Initiates ProQR Therapeutics(PRQR.US) With Buy Rating, Announces Target Price $5
ProQR Therapeutics Assumed With an Overweight at Cantor Fitzgerald
ProQR Therapeutics Initiated With an Outperform at Evercore ISI
ProQR Therapeutics Names Hom as CFO, Lopez Lopez as Chief Medical Officer
ProQR Strengthens Leadership With Appointments of CFO and CMO to Support Next Phase of Growth
ProQR Therapeutics Announces Appointment of Dennis Hom as Chief Financial Officer >PRQR